Virtus Health Ltd (ASX: VRT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Virtus Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $681.23 million
P/E Ratio 22.94
Dividend Yield 3.07%
Shares Outstanding 87.11 million
Earnings per share 0.341
Dividend per share 0.24
Year To Date Return 20.29%
Earnings Yield 4.36%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Virtus Health Ltd (ASX: VRT)
Latest News

A couple smile as they look at a pregnancy test.
Mergers & Acquisitions

Here’s why the Virtus share price is defying Friday’s sell-off

Virtus shareholders might be anticipating the announcement of a 30 cent special dividend next week.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Why is the CSL share price losing ground on Friday?

Why are CSL shares missing out on the market's gains on Friday?

Read more »

a doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Virtus share price holds steady despite 30% earnings fall

Shareholders are staying loyal with a looming acquisition.

Read more »

APA share price takeover Two colleagues take on another two colleagues in a tug of war in a high rise building.
Healthcare Shares

Virtus Health share price on ice as takeover battle heats up

Virtus Health has received yet another takeover bid. Here are the details.

Read more »

a couple in a bed hold a baby each up in the air, indicating they are the parents of twins. They look happy as they hold the babies aloft.
Mergers & Acquisitions

Here’s why the Virtus Health share price outperformed today

The company has been posed yet another takeover offer.

Read more »

A health professional wearing a stethoscope and scrubs shrugs with uncertainty.
Dividend Investing

Why is the Virtus Health (ASX:VRT) share price slipping today?

It seems the experts are split about which direction Virtus shares will go next.

Read more »

A man points at a paper as he holds an alarm clock.
Healthcare Shares

Time is running out to secure this ASX healthcare share dividend

Investors only have until the end of trading today to get hold of the latest Virtus Health dividend.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
52-Week Highs

Virtus Health (ASX:VRT) hits 52-week high, accepts CapVest bid

Here's the latest from Virtus Health today.

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
17 Jun 2022 $0.3000 100.00% Special Cash 01 Jul 2022
23 Mar 2022 $0.1200 100.00% Interim 14 Apr 2022
08 Oct 2021 $0.1200 100.00% Final 29 Oct 2021
24 Mar 2021 $0.1200 100.00% Interim 15 Apr 2021
25 Mar 2020 $0.1200 100.00% Interim 30 Nov 2020
03 Oct 2019 $0.1200 100.00% Final 25 Oct 2019
28 Mar 2019 $0.1200 100.00% Interim 18 Apr 2019
13 Sep 2018 $0.1200 100.00% Final 12 Oct 2018
28 Mar 2018 $0.1400 100.00% Interim 17 Apr 2018
14 Sep 2017 $0.1200 100.00% Final 13 Oct 2017
30 Mar 2017 $0.1300 100.00% Interim 18 Apr 2017
15 Sep 2016 $0.1500 100.00% Final 14 Oct 2016
31 Mar 2016 $0.1400 100.00% Interim 15 Apr 2016
30 Sep 2015 $0.1400 100.00% 16 Oct 2015
31 Mar 2015 $0.1300 100.00% 15 Apr 2015
30 Sep 2014 $0.1400 100.00% Final 16 Oct 2014
31 Mar 2014 $0.1200 100.00% Interim 17 Apr 2014

VRT ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Virtus Health Ltd

Virtus Health Ltd is an Australian company engaged in the provision of healthcare services like fertility services, medical day procedure services, and medical diagnostic services. Its operating segment includes Healthcare Services Australia and Healthcare Services International. The company generates maximum revenue from the Healthcare Services Australia segment.

VRT Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
24 Jun 2022 $7.82 $-0.04 -0.51% 31,038 $7.85 $7.95 $7.80
23 Jun 2022 $7.86 $0.06 0.77% 4,263 $7.80 $7.86 $7.80
22 Jun 2022 $7.80 $-0.03 -0.38% 94,032 $7.83 $7.86 $7.77
21 Jun 2022 $7.83 $-0.02 -0.25% 36,911 $7.87 $7.87 $7.83
20 Jun 2022 $7.85 $0.02 0.26% 45,917 $7.83 $7.87 $7.83
17 Jun 2022 $7.83 $-0.33 -4.04% 205,327 $8.12 $8.20 $7.83
16 Jun 2022 $8.16 $0.02 0.25% 148,956 $8.15 $8.20 $8.13
15 Jun 2022 $8.14 $-0.02 -0.25% 149,269 $8.15 $8.28 $8.13
14 Jun 2022 $8.16 $0.00 0.00% 79,301 $8.14 $8.17 $8.12
10 Jun 2022 $8.16 $0.03 0.37% 396,525 $8.15 $8.19 $8.15
09 Jun 2022 $8.13 $-0.02 -0.25% 271,815 $8.15 $8.16 $8.13
08 Jun 2022 $8.15 $-0.02 -0.24% 253,018 $8.14 $8.16 $8.14
07 Jun 2022 $8.17 $0.02 0.25% 259,673 $8.15 $8.17 $8.14
06 Jun 2022 $8.15 $0.00 0.00% 99,623 $8.15 $8.16 $8.14
03 Jun 2022 $8.15 $0.00 0.00% 222,039 $8.15 $8.17 $8.14
02 Jun 2022 $8.15 $0.00 0.00% 1,390,441 $8.15 $8.17 $8.13
01 Jun 2022 $8.15 $0.04 0.49% 512,854 $8.15 $8.25 $8.14
31 May 2022 $8.11 $-0.04 -0.49% 738,899 $8.15 $8.16 $8.11
30 May 2022 $8.15 $0.07 0.87% 696,837 $8.15 $8.15 $8.05
27 May 2022 $8.08 $-0.07 -0.86% 788,453 $8.02 $8.16 $7.80
26 May 2022 $8.15 $0.00 0.00% 167,826 $8.15 $8.17 $8.11

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Jun 2022 Kate Munnings Issued 369 $3,001,498
Conversion of securities.
09 Jun 2022 Kate Munnings Exercise 369 $3,001,498
Conversion of securities.
23 Mar 2022 Kate Munnings Issued 54 $438,037
Conversion of securities.
23 Mar 2022 Kate Munnings Exercise 54 $438,037
Conversion of securities. 369,188 - Performance Rights
23 Nov 2021 Kate Munnings Issued 111 $604,351
Issue of securities. 423,200 - Performance Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Ms Kate Munnings Chief Executive OfficerExecutive Director Mar 2020
Ms Munnings has more than 30 years of professional and operational experience. Prior to joining Virtus Health, Kate led operations including as Chief Operating Officer of Ramsay Health Care Limited's 72 Australian hospitals; and as Chief Executive, Operations leading a portfolio of largely government contracts across Australia, New Zealand and Melanesia at Transfield Services Limited.
Mr Lyndon Grant Hale Executive Director May 2013
Mr Hale has been the Medical Director of Melbourne IVF Pty Ltd from 2008 - 2020. He is a fertility specialist and gynaecologist with 30 years of experience at the forefront of fertility treatment and brings this experience in assisted reproduction treatments to the care of his patients. He is a member of the Risk committee.
Ms Sonia Petering Non-Executive DirectorNon-Executive Chairman Sep 2014
Ms Petering has more than 15 years of experience in non-executive director and chair roles with listed and unlisted companies and government authorities across financial services, payments, insurance, professional services and healthcare. Sonia is also an experienced commercial lawyer who commenced her own legal practice in 2001. She continues to be engaged on advisory and recruitment panels including advising the Minister for Water in relation to election of board members for the 18 water corporation boards across Victoria. Sonia previously served as a non-executive director on the boards of Transport Accident Commission of Victoria and Rural Finance Corporation of Victoria and as Chair of the Board of Rural Finance Corporation from 2009 - 2016. Sonia is also a non-executive director of TAL Dai - ichi Australia Ltd and Qantm IP (ASX:QIP). She is a member of the Risk committee.
Mr Greg Couttas Non-Executive Director Oct 2016
Mr Couttas has spent 40 years with Deloitte including 28 years as partner. In his years at Deloitte he worked in audit across various sectors, in ASX100 clients. Greg's experience includes accounting, finance, auditing, risk management, corporate governance, capital markets and due diligence. Greg held a number of management roles at Deloitte including being the Managing Partner for NSW from 2005 to 2008. He was a member of the Deloitte Australia Board of Partners from 2005 to 2016 and was chair of the Audit and Risk Committee for eleven years. He is a member of the Risk committee.
Ms Catherine (Cathy) Ann Aston Non-Executive Director Sep 2021
Ms Aston had an executive career at Telstra where she moved across roles in finance, marketing and strategy, including as the Finance Director of the International Division where she was based in Hong Kong and New Delhi and as Chief Executive of a mobile phone company based in Colombo. Cathy's executive roles each had a focus on enabling the business to improve its customer service and to operate more effectively and efficiently through better use of technology. Since 2013, Cathy has held a range of non-executive director roles and has also worked as a business advisor with a range of clients. Most recently, Cathy has worked with the NSW Government to improve outcomes across an array of programs and is currently a nonexecutive director with Macquarie Investment Management Ltd, IMB Bank Ltd, IVE Group (ASX: IGL) and Over the Wire Holdings (ASX: OTW), with the latter two roles also including Chair of Audit, Risk and Compliance committees. Cathy's non-executive director experience also includes serving as an Advisory Board Member of Avanseus, an AI business based out of Singapore.
Dr Priscilla Rogers Non-Executive Director Sep 2021
Dr Rogers has had direct experience in how technology innovation can transform industries and improve lives. She has spent her career in the research, development and translation of new technologies including medical devices, artificial intelligence (AI) and digital health solutions, including leading the Cognitive Health & Life Sciences portfolio at IBM Research Australia. Priscilla is currently a director and co-founder of Doftek, which is commercializing the active wheel alignment systems for vehicles; as well as a director and co-founder of Grean Brands, which is a health and wellness company responsible for developing and commercializing new antimicrobial prevention products. Priscilla previously co-founded IntelliMedical, which developed steerable guide wires for minimally invasive surgical procedures and was acquired by Merit Medical (NASDAQ: MMSI) in 2017. Priscilla's non-executive director roles include serving on the Board of the Digital Health Cooperative Research Centre and the Board of Australian Dementia Network Limited.
Ms Ava Bentley Group General Manager-Legal & RiskCompany Secretary May 2021
-
Matthew Prior Chief Financial Officer
-
Richard Banks Chief Strategy Officer (CSO) and European Managing Director
-
Ava Bentley Group General Manager-Legal & RiskCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Paradice Investment Mgt 7,431,947 8.70%
Yarra Capital Mgt 7,374,259 8.60%
Wilson Asset Mgt 5,292,656 6.20%
Dimensional Fund Advisors 4,411,125 5.20%
Vinva Investment Mgt 3,225,895 3.80%
Merlon Capital Partners 2,434,948 2.80%
Macquarie Securities 1,905,730 2.20%
Vanguard Group 1,671,279 2.00%
Eley Griffiths Group 1,460,714 1.70%
Auscap Asset Mgt 1,350,000 1.60%
Realindex Investments 1,309,480 1.50%
Vanguard Investments Australia 1,285,276 1.50%
Norges Bank Investment Mgt 1,191,815 1.40%
Plato Investment Mgt 1,189,534 1.40%
Acadian Asset Mgt (Australia) 1,113,810 1.30%
Ausbil Investment Mgt 1,089,050 1.30%
JPMorgan Securities Australia 965,489 1.10%
1851 Capital 940,220 1.10%
Mr Lyndon G Hale 826,572 1.00%
Ellerston Capital 728,927 0.90%

Profile

since

Note